Decisions of the Annual General Meeting of Shareholders of AUGA group, AB, under restructuring which took place on 22 May 2026
Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia
SafeSpace Global Announces New Senior Living Client; Clearview Healthcare Management, Expanding Deployment Across Seven Tennessee Facilities
Futu Receives Investigation Notice and Administrative Penalty Pre-Notification Letter from the China Securities Regulatory Commission
Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious...
